A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
Digital therapeutics company Akili is planning to merge with Virtual Therapeutics. Upon closing, the combined organization would operate as privately held Virtual Therapeutics, with Akili as a wholly ...
Akili Interactive is kicking off 2023 with the goal of shrinking its operational footprint and cutting costs to help expand the commercial reach of its digital therapeutics—a trade-off that will cost ...
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback